Suspended
Pembrolizumab in Neoplasms or Lymphomas
NCT03316573
- Conditions
- Dendritic Cell Sarcoma, Follicular, Dendritic Cell Sarcoma, Interdigitating, Follicular Dendritic Cell Sarcoma, +12 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- University of Nebraska Omaha, Nebraska, United States